Histogenics Corp. | Ownership

Companies that own Histogenics Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Perceptive Advisors LLC
2,203,277
7.68%
0
0.15%
06/30/2018
Fidelity Management & Research Co.
1,633,054
5.69%
-96,566
0%
07/31/2018
S Squared Technology LLC
1,169,387
4.08%
20,000
2.46%
06/30/2018
The Vanguard Group, Inc.
919,769
3.21%
528
0%
06/30/2018
Renaissance Technologies LLC
384,329
1.34%
22,133
0%
06/30/2018
Palo Alto Investors LP
302,922
1.06%
0
0.03%
06/30/2018
Archon Capital Management LLC
293,090
1.02%
60,772
0.47%
06/30/2018
Bridgeway Capital Management, Inc.
150,000
0.52%
0
0%
06/30/2018
Apo Asset Management GmbH
141,418
0.49%
82,618
0.02%
06/29/2018
DWS Investment GmbH
126,249
0.44%
2,353
0%
06/30/2018

About Histogenics

View Profile
Address
830 Winter Street
Waltham Massachusetts 02451
United States
Employees -
Website http://www.histogenics.com
Updated 07/08/2019
Histogenics Corp. engages in the development, marketing, and commercialization of musculoskeletal medicine. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA.